HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
期刊
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
卷 8, 期 6, 页码 307-309出版社
NATURE PUBLISHING GROUP
关键词
作者
我是这篇论文的作者
推荐
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
Antonietta G. Gravina, Kateryna Priadko, Lucia Granata, Angela Facchiano, Giuseppe Scida, Rosa Cerbone, Paola Ciamarra, Marco Romano
FRONTIERS IN PHARMACOLOGY (2021)
Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates
Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh, Chul-Hyun Lim
JOURNAL OF CLINICAL MEDICINE (2021)
Single-capsule bismuth-based quadruple therapy as a rescue therapy for Helicobacter pylori eradication
Catarina Correia, Nuno Almeida, Carina Leal, Diogo Branquinho, Alexandra Fernandes, Elisa Gravito-Soares, Carlos Calhau, Isabel Bastos, Helena Vasconcelos, Pedro Figueiredo
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)
Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children
Kallirroi Kotilea, Samy Cadranel, Assaad Salame, Julie Nguyen, Tania Mahler, Veronique Yvette Miendje Deyi, Laurine Verset, Patrick Bontems
HELICOBACTER (2021)
Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
Zhan-Yue Niu, Si-Zhu Li, Yan-Yan Shi, Yan Xue
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
Ki Young Huh, Hyewon Chung, Yu Kyong Kim, SeungHwan Lee, Siddharth Bhatia, Yohei Takanami, Ryou Nakaya, Kyung-Sang Yu
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial
Jinnan Chen, Yixian Guo, Yu Huang, Zhaohui Ding, Jing Wang, Xiao Liang, Ping Xu, Yaohua Han, Hong Lu
JOURNAL OF INFECTIOUS DISEASES (2023)
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis
Yu-Ming Ding, Yue-Yue Li, Jing Liu, Juan Wang, Meng Wan, Min-Juan Lin, Bo-Shen Lin, Wen-Lin Zhang, Qing-Zhou Kong, Shao-Tong Wang, Yi-Jun Mu, Miao Duan, Zhong-Xue Han, Xiu-Li Zuo, Yan-Qing Li
CLINICAL AND EXPERIMENTAL MEDICINE (2023)
A Simplified Low-Dose 10-Day Quadruple Therapy with a Galenic Formulation of Bismuth Salicylate Is Highly Effective for Helicobacter pylori Eradication
Maria Pina Dore, Francesco Saba, Lucia Zanni, Anna Rocca, Jessica Piroddu, Giuseppe Gutierrez, Giovanni Mario Pes
JOURNAL OF CLINICAL MEDICINE (2023)
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
Min Niu, Yan Zhou, Yunqian Xie, Xue Li, Yonggang Tian, Li Yao, Ximei Li, Hengjun Gao, Feihu Bai
FRONTIERS IN PHARMACOLOGY (2022)
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice
Olga P. Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, Rinaldo Pellicano, Jose M. Huguet, Luis Rodrigo, Juan Ortuno, Blas J. Gomez-Rodriguez, Ricardo M. Pinto, Miguel Areia, Monica Perona, Oscar Nunez, Marco Romano, Antonietta G. Gravina, Liliana Pozzati, Miguel Fernandez-Bermejo, Marino Venerito, Peter Malfertheiner, Luis Fernanadez-Salazar, Antonio Gasbarrini, Dino Vaira, Ignasi Puig, Francis Megraud, Colm O'Morain, Javier P. Gisbert
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
A new option in Helicobacter pylori eradication: High-dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting
Vitor Macedo Silva, Tiago Lima Capela, Marta Freitas, Pedro Boal Carvalho, Joana Magalhaes, Jose Cotter
HELICOBACTER (2023)
14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial
Qinyu Yang, Cong He, Yi Hu, Junbo Hong, Zhenhua Zhu, Yong Xie, Xu Shu, Nonghua Lu, Yin Zhu
FRONTIERS IN PHARMACOLOGY (2023)
Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
Junxian Wang, Yuping Cao, Wei He, Xiaoping Li
MEDICINE (2021)
Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study
Peng Qu, Xiaoming Liu, Xiujuan Xia, Xiaoran Xie, Ju Luo, Sha Cheng, Jingshu Chi, Peng Liu, Huan Li, Wenfang Zhao, Huihao Yang, Canxia Xu
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management
Luigi Gatta, Olga P. Nyssen, Giulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, Marco Romano, Antonietta Gerarda Gravina, Lucia Granata, Rinaldo Pellicano, Antonio Gasbarrini, Alfredo Di Leo, Giuseppe Losurdo, Francesco Franceschi, Gerardo Nardone, Alba Rocco, Maria Pina Dore, Fabio Farinati, Matteo Ghisa, Massimo Bellini, John Holton, Ignasi Puig, Dino Vaira, Claudio Borghi, Francis Megraud, Colm O'Morain, Javier P. Gisbert
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs
Rosario Medina-Medina, Eva Iglesias-Flores, Jose M. Benitez, Sandra Marin-Pedrosa, Isabel Salgueiro-Rodriguez, Clara I. Linares, Sandra Gonzalez-Rubio, Pilar Soto-Escribano, Beatriz Gros, Manuel L. Rodriguez-Peralvarez, Jose L. Cabriada, Maria Chaparro, Javier P. Gisbert, Eduardo Chicano-Galvez, Ignacio Ortea, Gustavo Ferrin, Valle Garcia-Sanchez, Patricia Aguilar-Melero
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
Montse Baldan-Martin, Maria Chaparro, Javier P. Gisbert
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically
Emily K. Wright, Maria Chaparro, Paolo Gionchetti, Amy L. Hamilton, Julien Schulberg, Javier P. Gisbert, Maria Chiara Valerii, Fernando Rizzello, Peter De Cruz, John C. Panetta, Annelie Everts-van der Wind, Michael A. Kamm, Thierry Dervieux
JOURNAL OF CROHNS & COLITIS (2023)
De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review
Javier P. Gisbert, Maria Chaparro
JOURNAL OF CROHNS & COLITIS (2023)
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013-2022: Data from the European Registry on H. pylori Management (Hp-EuReg)
Olga. P. Nyssen, Pietro Pratesi, Miguel. A. Spinola, Laimas Jonaitis, Angeles Perez-Aisa, Dino Vaira, Ilaria Maria Saracino, Matteo Pavoni, Giulia Fiorini, Bojan Tepes, Dmitry. S. Bordin, Irina Voynovan, Angel Lanas, Samuel. J. Martinez-Dominguez, Enrique Alfaro, Luis Bujanda, Manuel Pabon-Carrasco, Luis Hernandez, Antonio Gasbarrini, Juozas Kupcinskas, Frode Lerang, Sinead. M. Smith, Oleksiy Gridnyev, Marcis Leja, Theodore Rokkas, Ricardo Marcos-Pinto, Antonio Mestrovic, Wojciech Marlicz, Vladimir Milivojevic, Halis Simsek, Lumir Kunovsky, Veronika Papp, Perminder. S. Phull, Marino Venerito, Lyudmila Boyanova, Doron Boltin, Yaron Niv, Tamara Matysiak-Budnik, Michael Doulberis, Daniela Dobru, Vincent Lamy, Lisette. G. Capelle, Emilijia Nikolovska Trpchevska, Leticia Moreira, Anna Cano-Catalia, Pablo Parra, Francis Megraud, Colm O'Morain, Guillermo. J. Ortega, Javier. P. Gisbert
ANTIBIOTICS-BASEL (2023)
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease
Irene Soleto, Cristina Ramirez, Cristina Gomez, Montse Baldan-Martin, Macarena Orejudo, Jorge Mercado, Maria Chaparro, Javier P. Gisbert
BIOMEDICINES (2023)
The Costs of Inflammatory Bowel Diseases in High-Income Settings
J. Burisch, M. Zhao, S. Odes, P. De Cruz, S. Vermeire, C. N. Bernstein, G. G. Kaplan, D. Duricova, D. Greenberg, H. O. Melberg, M. Watanabe, H. S. Ahn, L. Targownik, V. E. H. Pittet, V. Annese, K. Park, K. H. Konstantinos H, M. L. Hoivik, Z. Krznaric, M. Chaparro, E. V. Loftus, P. L. Lakatos, J. P. Gisbert, W. Bemelman, B. Moum, R. B. Gearry, M. D. Kappelman, A. Hart, M. Pierik, J. Andrews, S. Ng, R. D'Inca, P. Munkholm
JOURNAL OF CROHNS & COLITIS (2023)
HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry
M. Calafat Sard, C. Suria, F. Mesonero, R. de Francisco, C. Yague Caballero, L. de la Pena, A. Hernandez-Camba, A. Marce, B. Gallego, N. Martin-Vicente, M. Rivero, M. Iborra, I. Guerra, M. Carrillo-Palau, L. Madero, B. Burgueno, D. Montfort, G. Torres, M. Teller, J. A. Ferrer Rosique, P. Vega Villaamil, C. Roig, A. Ponferrada, E. Betore Glaria, Y. Zabana, J. P. Gisbert, N. Alcaide, B. Camps, J. Legido, M. Gonzalez Vivo, M. M. Bosca-Watts, I. Perez-Martinez, D. Casas Deza, J. Guardiola, L. Arranz Hernandez, M. Navarro, F. Gomollon, F. Canete, M. Manosa, E. Domenech
JOURNAL OF CROHNS & COLITIS (2023)
COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS ANTI-TNFs IN ULCERATIVE COLITIS BIO-NAIVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNFα (EVOLVE-IBERIA STUDY)
F. Casellas Jorda, C. Rodriguez, J. P. Gisbert, S. Bernardo, J. Aparicio, I. Tagarro, F. Munoz
JOURNAL OF CROHNS & COLITIS (2023)
Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases
M. Chaparro, D. Acosta, C. Rodriguez, F. Mesonero, M. Vicuna, M. Barreiro-de Acosta, A. Fernandez-Clotet, A. Hernandez Martinez, M. Arroyo, I. Vera, A. Ruiz-Cerulla, B. Sicilia, M. J. Cabello Tapia, C. Munoz Villafranca, J. Castro-Poceiro, J. Martinez Cadilla, M. Sierra-Ausin, M. Vazquez Moron, E. Montil Miguel, F. Bermejo, V. Royo, M. Calafat, C. Gonzalez-Munoza, E. Leo Carnerero, N. Mancenido Marcos, L. Torrealba, H. Alonso-Galan, M. Benitez, Y. Ber Nieto, M. T. Diz-Lois Palomares, M. J. Garcia, J. F. Munoz, E. M. Armesto Gonzalez, X. Calvet, A. Hernandez-Camba, R. E. Madrigal Dominguez, L. Menchen, J. L. Perez Calle, M. Piqueras, J. P. Gisbert
JOURNAL OF CROHNS & COLITIS (2023)
Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry.
M. Calafat Sard, I. Pascual, P. Nos, J. Barrio, A. Gutierrez, M. D. Martin-Arranz, E. Ricart, F. Gomollon, M. Sierra Ausin, J. M. Huguet, J. Guardiola, I. Vera, P. Varela, E. Iglesias, E. Garcia-Planella, L. de Castro, M. F. Garcia Sepulcre, B. Sicilia, L. Fernandez-Salazar, X. Calvet, F. Munoz, S. Garcia-Lopez, F. Bermejo, L. Ramos, P. Martinez Montiel, R. Lorente, J. L. Cabriada, M. Piqueras, I. Marin-Jimenez, M. Esteve, F. Mesonero, E. Sese, J. P. Gisbert, L. Marquez, D. Busquets, R. Pajares, F. Canete, M. Manosa, E. Domenech
JOURNAL OF CROHNS & COLITIS (2023)
Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study
P. Sanz Segura, F. Gomollon, S. Garcia Garcia, M. Vela, A. Fernandez-Clotet, R. Munoz, I. Garcia de la Filia, M. Garcia Prada, J. A. Ferrer Rosique, M. J. Garcia, R. de Francisco, L. Arias, J. Barrio, I. Guerra, A. Ponferrada Diaz, J. P. Gisbert, M. Carrillo-Palau, X. Calvet, L. Marquez-Mosquera, B. Gros, F. Canete, D. Monfort, R. E. Madrigal, O. Roncero, V. Laredo, M. Montoro, C. Munoz, B. Lopez-Cauce, R. Lorente, A. Fuentes, P. Vega, D. Martin, J. Nerin de la Puerta, P. Varela, D. Casas-Deza, P. Martinez, R. Pajares, A. J. Lucendo, E. Domenech, S. Garcia-Lopez
JOURNAL OF CROHNS & COLITIS (2023)
Immunological effects of hepatitis B virus vaccination in inflammatory bowel disease patients
I. Soleto, A. C. Marin, I. Mora, J. R. Villagrasa, M. Baldan-Martin, C. Ramirez, D. Bernardo, M. Chaparro, J. P. Gisbert
JOURNAL OF CROHNS & COLITIS (2023)
Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease
I. Soleto, M. Baldan, C. Ramirez, M. Orejudo, S. Garcia, J. Mercado, M. Azkargorta, I. Lloro, L. Ortega Moreno, L. Aldars Garcia, S. Riestra, M. Rivero, A. Gutierrez, I. Rodriguez-Lago, L. Fernandez, D. Ceballos, J. M. Benitez, M. Aguas, I. Baston Rey, F. Bermejo, M. J. Casanova, R. Lorente, Y. Ber, D. Ginard, M. Esteve, F. Elortza, J. P. Gisbert, N. Martin-Cofreces, M. Chaparro
JOURNAL OF CROHNS & COLITIS (2023)